Tenet Non Currrent Assets Other vs Net Receivables Analysis
THC Stock | USD 132.97 4.41 3.43% |
Tenet Healthcare financial indicator trend analysis is much more than just breaking down Tenet Healthcare prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tenet Healthcare is a good investment. Please check the relationship between Tenet Healthcare Non Currrent Assets Other and its Net Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.
Non Currrent Assets Other vs Net Receivables
Non Currrent Assets Other vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tenet Healthcare Non Currrent Assets Other account and Net Receivables. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Tenet Healthcare's Non Currrent Assets Other and Net Receivables is 0.12. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Tenet Healthcare, assuming nothing else is changed. The correlation between historical values of Tenet Healthcare's Non Currrent Assets Other and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Tenet Healthcare are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Non Currrent Assets Other i.e., Tenet Healthcare's Non Currrent Assets Other and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.12 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Net Receivables
Most indicators from Tenet Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tenet Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.At present, Tenet Healthcare's Enterprise Value Over EBITDA is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 8.91, whereas Selling General Administrative is forecasted to decline to about 7 B.
2021 | 2022 | 2024 (projected) | Interest Expense | 923M | 890M | 738.0M | Depreciation And Amortization | 625M | 1.1B | 537.1M |
Tenet Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Tenet Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tenet Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 23.4B | 27.1B | 27.6B | 27.2B | 28.3B | 29.7B | |
Short Long Term Debt Total | 14.8B | 15.7B | 15.6B | 15.1B | 16.2B | 17.0B | |
Other Current Liab | 1.4B | 2.8B | 2.7B | 2.7B | 3.0B | 3.1B | |
Total Current Liabilities | 4.2B | 4.8B | 5.1B | 4.5B | 4.8B | 2.5B | |
Total Stockholder Equity | (371M) | 28M | 1.0B | 1.1B | 1.6B | 1.3B | |
Property Plant And Equipment Net | 6.9B | 6.7B | 6.4B | 6.5B | 7.3B | 5.4B | |
Net Debt | 14.5B | 13.3B | 13.3B | 14.2B | 15.0B | 15.7B | |
Retained Earnings | (2.5B) | (2.1B) | (1.2B) | (803M) | (192M) | (201.6M) | |
Cash | 262M | 2.4B | 2.4B | 858M | 1.2B | 1.3B | |
Non Current Assets Total | 18.3B | 20.0B | 20.5B | 21.2B | 21.1B | 22.2B | |
Non Currrent Assets Other | 308M | 315M | 317M | 389M | 180M | 209.6M | |
Cash And Short Term Investments | 262M | 2.4B | 2.4B | 858M | 1.2B | 1.3B | |
Net Receivables | 2.8B | 2.7B | 2.8B | 2.9B | 4.0B | 4.2B | |
Common Stock Shares Outstanding | 103.4M | 106.3M | 108.6M | 110.5M | 104.8M | 108.1M | |
Liabilities And Stockholders Equity | 23.4B | 27.1B | 27.6B | 27.2B | 28.3B | 29.7B | |
Non Current Liabilities Total | 17.2B | 19.4B | 18.2B | 18.1B | 18.0B | 18.9B | |
Inventory | 310M | 368M | 384M | 405M | 411M | 212.3M | |
Other Current Assets | 1.4B | 1.5B | 1.6B | 1.8B | 1.5B | 1.6B | |
Other Stockholder Equity | 2.3B | 2.4B | 2.5B | 2.1B | 2.0B | 2.6B | |
Total Liab | 21.4B | 24.2B | 23.3B | 22.5B | 22.8B | 23.9B | |
Property Plant And Equipment Gross | 8.0B | 7.9B | 13.5B | 13.8B | 13.8B | 14.5B | |
Total Current Assets | 5.1B | 7.1B | 7.1B | 6.0B | 7.2B | 7.5B | |
Accumulated Other Comprehensive Income | (257M) | (281M) | (233M) | (181M) | (208.2M) | (218.6M) | |
Short Term Debt | 182M | 171M | 145M | 135M | 324M | 340.2M | |
Intangible Assets | 1.6B | 1.6B | 1.5B | 1.4B | 1.4B | 1.4B | |
Other Liab | 1.7B | 3.8B | 2.7B | 2.1B | 2.4B | 1.7B | |
Other Assets | 646M | 325M | 65M | 19M | 21.9M | 20.8M | |
Long Term Debt | 14.6B | 15.6B | 15.5B | 14.9B | 14.9B | 9.6B | |
Good Will | 7.3B | 8.8B | 9.3B | 10.1B | 10.3B | 10.8B | |
Property Plant Equipment | 7.8B | 6.7B | 6.4B | 6.5B | 7.4B | 6.6B | |
Current Deferred Revenue | 1.5B | 659M | 959M | 110M | 59M | 56.1M | |
Net Tangible Assets | (7.7B) | (8.4B) | (9.7B) | (8.3B) | (7.4B) | (7.8B) | |
Noncontrolling Interest In Consolidated Entity | 854M | 909M | 1.0B | 1.3B | 1.5B | 1.6B | |
Retained Earnings Total Equity | (2.5B) | (2.1B) | (1.2B) | (803M) | (722.7M) | (758.8M) | |
Long Term Debt Total | 14.6B | 15.6B | 15.5B | 14.9B | 17.2B | 13.1B |
Currently Active Assets on Macroaxis
When determining whether Tenet Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenet Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenet Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenet Healthcare Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.Note that the Tenet Healthcare information on this page should be used as a complementary analysis to other Tenet Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Tenet Stock analysis
When running Tenet Healthcare's price analysis, check to measure Tenet Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenet Healthcare is operating at the current time. Most of Tenet Healthcare's value examination focuses on studying past and present price action to predict the probability of Tenet Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenet Healthcare's price. Additionally, you may evaluate how the addition of Tenet Healthcare to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Tenet Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenet Healthcare. If investors know Tenet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenet Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 15.189 | Earnings Share 25.78 | Revenue Per Share 206.929 | Quarterly Revenue Growth 0.068 | Return On Assets 0.0661 |
The market value of Tenet Healthcare is measured differently than its book value, which is the value of Tenet that is recorded on the company's balance sheet. Investors also form their own opinion of Tenet Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tenet Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenet Healthcare's market value can be influenced by many factors that don't directly affect Tenet Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenet Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenet Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenet Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.